Normal and abnormal inflammatory response
Background
Inflammation is a complex biological response of body tissues to harmful stimuli, including pathogens, damaged cells, toxic compounds, or irritants. It is a protective response involving immune cells, blood vessels, and molecular mediators, designed to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.Initial tissue response to injury - phases of inflammation
1. Vascular Phase (Immediate - Minutes)
- Transient vasoconstriction (seconds) followed by vasodilation
- Increased vascular permeability due to endothelial cell contraction
- Plasma protein extravasation leads to tissue oedema
- Slowing of blood flow facilitates cellular events
2. Cellular/Exudative Phase (Minutes to Hours)
- Neutrophil recruitment: first responders arrive within minutes to hours
- Monocyte/macrophage infiltration: arrive hours to days later
- Lymphocyte recruitment: involved in later phases and chronic inflammation
- Cellular migration occurs through chemotaxis and adhesion molecules
3. Resolution/Repair Phase (Days to Weeks)
- Clearance of inflammatory cells and debris
- Tissue repair and regeneration
- Return to homeostasis or progression to chronic inflammation
Cardinal signs of inflammation
The five classical signs of inflammation (described by Celsus and later Virchow):
The five classical signs of inflammation (described by Celsus and later Virchow):
- 1. Rubor (Redness) - due to vasodilation
- 2. Calor (Heat) - increased blood flow and metabolic activity
- 3. Tumor (Swelling) - fluid accumulation from increased vascular permeability
- 4. Dolor (Pain) - pressure from swelling and chemical mediators
- 5. Functio laesa (Loss of function) - combination of above factors
Causes of inflammation
| Cause category | Mechanisms |
|---|---|
| Physical |
|
Chemical |
|
Electrical |
|
Biological |
|
Cellular events in inflammation
Chemotaxis
The directed migration of cells along a chemical gradient toward inflammatory sites. Key chemotactic factors include:
- Complement fragments (C5a, C3a)
- Bacterial products (N-formyl peptides)
- Cytokines (IL-8, MCP-1)
- Leukotriene B4
Opsonization
The coating of pathogens or particles with molecules that enhance phagocytosis:
- Complement proteins (C3b, iC3b)
- Antibodies (IgG, IgM)
- Collectins (mannose-binding lectin)
- Acute phase proteins (C-reactive protein)
Phagocytosis
The process by which cells engulf and digest foreign particles:
1. Recognition and binding of opsonized particles
2. Engulfment - formation of phagosome
3. Phagolysosome formation - fusion with lysosomes
4. Intracellular killing and digestion
Intracellular Killing Mechanisms
Oxygen-dependent killing:- Respiratory burst producing reactive oxygen species (ROS)
- Superoxide, hydrogen peroxide, hydroxyl radicals
- Myeloperoxidase system producing hypochlorous acid
Oxygen-independent killing:
- Lysozyme: breaks down bacterial cell walls
- Lactoferrin: iron sequestration
- Defensins: antimicrobial peptides
- Elastase and other proteases
Chemical mediators of inflammation
Complement system
- Classical, alternative, and Lectin pathways
- C3a, C4a, C5a: anaphylatoxins causing vasodilation and increased permeability
- C5a (potent chemotactic factor)
- Membrane attack complex (C5b-9) leading to cell lysis
Histamine
- Released from mast cells and basophils
- Causes vasodilation and increased vascular permeability
- Smooth muscle contraction
Cytokines
- TNF-α: fever, acute phase response, endothelial activation
- IL-1: fever, acute phase response, T-cell activation
- IL-6: acute phase response, B-cell differentiation
- Interferons: antiviral activity, macrophage activation
- Chemokines: cellular recruitment (IL-8, MCP-1, RANTES)
Arachidonic acid metabolites
- Prostaglandins (PGE2, PGI2): vasodilation, pain, fever
- Leukotrienes (LTB4): chemotaxis, bronchoconstriction
- Thromboxanes: vasoconstriction, platelet aggregation
Other mediators
- Nitric oxide: vasodilation, antimicrobial activity
- Platelet-activating factor: platelet aggregation, increased permeability
- Kinins (bradykinin): pain, vasodilation, increased permeability
- Coagulation factors: tissue factor, thrombin
Effects of inflammation
Beneficial effects
- Pathogen elimination: antimicrobial activity
- Toxin dilution: increased blood flow washes out harmful substances
- Barrier formation: fibrin clot prevents spread
- Immune system activation: antigen presentation and adaptive immunity
- Tissue repair initiation: growth factors and repair cells
- Pain response: protective behavior modification
Harmful effects
- Tissue damage: from inflammatory mediators and ROS
- Organ dysfunction: due to edema and cellular infiltration
- Autoimmune reactions: molecular mimicry and epitope spreading
- Chronic inflammation: persistent tissue damage
- Systemic effects: fever, shock, organ failure
- Fibrosis: excessive scar tissue formation
Systemic signs of inflammation
Acute phase response
- Fever: IL-1, TNF-α, IL-6 acting on hypothalamus
- Leukocytosis
- Increased ESR and CRP
- Altered liver protein synthesis: decreased albumin, increased fibrinogen
Constitutional symptoms
- Malaise and fatigue
- Anorexia
- Sleep disturbances
- Myalgia
Cardiovascular effects
- Tachycardia
- Vasodilation (potential hypotension)
- Increased cardiac output
Possible outcomes of inflammation
Resolution (Complete Healing)
- Return to normal tissue architecture
- Restoration of function
- Clearance of inflammatory cells
- Ideal outcome with minimal tissue damage
Healing by Repair
- Scar tissue formation: when tissue cannot regenerate
- Fibroblast proliferation and collagen deposition
- May result in loss of function
- Angiogenesis
Suppuration (Pus Formation)
- Neutrophil-rich exudate
- Abscess formation
- May require surgical drainage
- Risk of systemic spread
Chronic inflammation
- Persistent inflammatory stimulus
- Lymphocyte and macrophage predominance
- Tissue destruction and fibrosis
- Granuloma formation in some cases
Fibrosis
- Excessive collagen deposition
- Loss of tissue architecture
- Impaired organ function
- May progress to organ failure
Abnormal inflammatory responses
Abnormal inflammation occurs when the inflammatory response is inappropriate in intensity, duration, or target, leading to tissue damage rather than protection and healing.
| Condition | Mechanism | Key Features |
|---|---|---|
| Allergic Reactions | IgE-mediated hypersensitivity; mast cell degranulation | Immediate onset; histamine release; can progress to anaphylaxis; affects skin, respiratory, and GI systems |
| Asthma | Th2-mediated airway inflammation; eosinophil infiltration | Bronchial hyperresponsiveness; mucus hypersecretion; airway remodeling; reversible airflow obstruction |
| Autoimmune Diseases | Loss of self-tolerance; molecular mimicry; immune complex formation | Systemic (SLE, RA) or organ-specific (T1DM, MS); chronic inflammation; tissue-specific autoantibodies |
| Chronic Inflammation | Persistent inflammatory stimuli; failed resolution mechanisms | Ongoing tissue damage; fibrosis; increased cancer risk; examples: IBD, chronic hepatitis |
| Transplant Rejection | Allorecognition; T-cell mediated immunity against foreign HLA | Acute or chronic; requires immunosuppression; can affect any transplanted organ |
| Vasculitis | Immune complex deposition; ANCA-associated; infection-triggered | Vessel wall inflammation; organ ischemia; systemic or localized; size-specific patterns |
| Sepsis/SIRS | Overwhelming inflammatory response; cytokine storm; endothelial dysfunction | Multi-organ failure; distributive shock; high mortality; requires intensive care |
| Inflammatory Bowel Disease | Dysregulated mucosal immunity; genetic predisposition; microbiome alterations | Chronic intestinal inflammation; Crohn's disease vs. ulcerative colitis; increased malignancy risk |
| Rheumatoid Arthritis | Synovial inflammation; pannus formation; joint destruction | Symmetric polyarthritis; systemic manifestations; rheumatoid factor and anti-CCP antibodies |
| Atherosclerosis | Chronic vascular inflammation; foam cell formation; plaque instability | Leading cause of cardiovascular disease; inflammatory markers predict risk; statin benefits beyond lipid lowering |
Key concepts in abnormal inflammation
- Hyperacute responses: excessive immediate reactions (anaphylaxis)
- Chronic persistence: failure of resolution mechanisms
- Misdirected immunity: autoimmune targeting of self-tissues
- Dysregulated repair: excessive fibrosis or inadequate healing
- Systemic complications: local inflammation causing distant organ dysfunction